Improving the function of liver grafts exposed to warm ischemia by the leuven drug protocol: Exploring the molecular basis by microarray

Liver Transplantation

Volumn 18, Issue 2, 2012, Pages 206-218

  Vekemans, Katrien ^a,b   Monbaliu, Diethard ^a   Balligand, Erika ^a   Heedfeld, Veerle ^a   Jochmans, Ina ^a   Pirenne, Jacques ^a   Van Pelt, Jos ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; ALPHA TOCOPHEROL; APOTRANSFERRIN; CYTOKINE; GLUTATHIONE; GLYCINE; OROSOMUCOID; PROSTACYCLIN; STREPTOKINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; GRAFT DYSFUNCTION; GRAFT SURVIVAL; ISCHEMIA; LEUVEN DRUG PROTOCOL; LIVER FUNCTION; LIVER GRAFT; LIVER PERFUSION; LIVER PROTECTION; LIVER TRANSPLANTATION; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; NONHUMAN; PRIMARY NONFUNCTION; PRIORITY JOURNAL; SWINE;

ALPHA-TOCOPHEROL; ANIMALS; APOPROTEINS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUTATHIONE; GLYCINE; GRAFT SURVIVAL; LIVER TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OROSOMUCOID; POSTOPERATIVE COMPLICATIONS; PROTECTIVE AGENTS; PYRAZOLES; PYRIDINES; REAL-TIME POLYMERASE CHAIN REACTION; SWINE; TIME FACTORS; TRANSFERRIN; WARM ISCHEMIA;

EID: 84856287088     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22446     Document Type: Article

References (73)

1. Oosterlee A, Rahmel A, eds. Eurotransplant International Foundation: Annual Report 2010. Leiden, the Netherlands: Eurotransplant International Foundation; 2009; 77-85.
2. Perera MT, Mirza DF, Elias E,. Liver transplantation: issues for the next 20 years. J Gastroenterol Hepatol 2009; 24 (suppl 3): S124-S131.
3. Durand F, Renz JF, Alkofer B, Burra P, Clavien PA, Porte RJ, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl 2008; 14: 1694-1707.
4. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF,. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87-92. (Pubitemid 38176377)
5. Abu-Amara M, Yang SY, Tapuria N, Fuller B, Davidson B, Seifalian A,. Liver ischemia/reperfusion injury: processes in inflammatory networks-a review. Liver Transpl 2010; 16: 1016-1032.
6. Klune JR, Tsung A,. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg Clin North Am 2010; 90: 665-677.
7. Clarke CN, Kuboki S, Tevar A, Lentsch AB, Edwards M,. CXC chemokines play a critical role in liver injury, recovery, and regeneration. Am J Surg 2009; 198: 415-419.
8. Katsargyris A, Klonaris C, Alexandrou A, Giakoustidis AE, Vasileiou I, Theocharis S,. Toll-like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation? Expert Opin Ther Targets 2009; 13: 427-442.
9. Kanamoto M, Shimada M, Morine Y, Yoshizumi T, Imura S, Ikegami T, et al. Beneficial effects of follistatin in hepatic ischemia-reperfusion injuries in rats. Dig Dis Sci 2011; 56: 1075-1081.
10. Pratap A, Panakanti R, Yang N, Eason JD, Mahato RI,. Inhibition of endogenous hedgehog signaling protects against acute liver injury after ischemia reperfusion. Pharm Res 2010; 27: 2492-2504.
11. Li JD, Peng Y, Peng XY, Li QL, Li Q,. Suppression of nuclear factor-κB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion injury. Transplant Proc 2010; 42: 1582-1586.
12. Freitas MC, Uchida Y, Zhao D, Ke B, Busuttil RW, Kupiec-Weglinski JW,. Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl 2010; 16: 600-610.
13. Liu YX, Jin LM, Zhou L, Xie HY, Jiang GP, Wang Y, et al. Mycophenolate mofetil attenuates liver ischemia/reperfusion injury in rats. Transpl Int 2009; 22: 747-756.
14. Song S, Liu N, Liu W, Shi R, Guo KJ, Liu YF,. The effect of pretreatment with calcitonin gene-related peptide on attenuation of liver ischemia and reperfusion injury due to oxygen free radicals and apoptosis. Hepatogastroenterology 2009; 56: 1724-1729.
15. Oshima K, Yabata Y, Yoshinari D, Takeyoshi I,. The effects of cyclooxygenase (COX)-2 inhibition on ischemia-reperfusion injury in liver transplantation. J Invest Surg 2009; 22: 239-245.
16. Yamaguchi K, Kawahara T, Kumakura S, Hua J, Kugimiya T, Nagaoka I, Inada E,. Effect of olprinone, a phosphodiesterase III inhibitor, on hepatic ischemia-reperfusion injury in rats. Shock 2010; 33: 436-441.
17. Schmeding M, Hunold G, Ariyakhagorn V, Rademacher S, Boas-Knoop S, Lippert S, et al. Erythropoietin reduces ischemia-reperfusion injury after liver transplantation in rats. Transpl Int 2009; 22: 738-746.
18. Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007; 117: 2583-2591. (Pubitemid 47494359)
19. Baskin-Bey ES, Washburn K, Feng S, Oltersdorf T, Shapiro D, Huyghe M, et al. Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant 2007; 7: 218-225. (Pubitemid 44952876)
20. Bogetti D, Sankary HN, Jarzembowski TM, Manzelli A, Knight PS, Thielke J, et al. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin Transplant 2005; 19: 507-511. (Pubitemid 40990661)
21. St Peter SD, Post DJ, Rodriguez-Davalos MI, Douglas DD, Moss AA, Mulligan DC,. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transpl 2003; 9: 144-149. (Pubitemid 36204565)
22. Monbaliu D, Crabbé T, Roskams T, Fevery J, Verwaest C, Pirenne J,. Livers from non-heart-beating donors tolerate short periods of warm ischemia. Transplantation 2005; 79: 1226-1230. (Pubitemid 40664029)
23. Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D'Alessandro A, et al.; for ASTS Standards on Organ Transplantation Committee. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009; 9: 2004-2011.
24. Monbaliu D, Van Gelder F, Troisi R, de Hemptinne B, Lerut J, Reding R, et al. Liver transplantation using non-heart-beating donors: Belgian experience. Transplant Proc 2007; 39: 1481-1484. (Pubitemid 46907909)
25. Monbaliu D, Vekemans K, Hoekstra H, Vaahtera L, Libbrecht L, Derveaux K, et al. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Ann Surg 2009; 250: 808-817.
26. Monbaliu DR, Dubuisson CN, Zeegers MM, Crabbé MM, Fevery JM, Pirenne JM, van Pelt JF,. Increased serum phospholipase A2 activity after non-heart-beating donor liver transplantation and association with ischemia-reperfusion injury. J Surg Res 2009; 151: 125-131.
27. Moussavian MR, Scheuer C, Schmidt M, Kollmar O, Wagner M, von Heesen M, et al. Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury. Langenbecks Arch Surg 2011; 396: 231-241.
28. Bioconductor. Accessed September 2011.
29. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289-300.
30. Tsai S, Cassady JP, Freking BA, Nonneman DJ, Rohrer GA, Piedrahita JA,. Annotation of the Affymetrix porcine genome microarray. Anim Genet 2006; 37: 423-424. (Pubitemid 44091679)
31. Salomonis N, Hanspers K, Zambon AC, Vranizan K, Lawlor SC, Dahlquist KD, et al. GenMAPP 2: new features and resources for pathway analysis. BMC Bioinformatics 2007; 8: 217.
32. Gene Ontology. Accessed September 2011.
33. STRING. Accessed September 2011.
34. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009; 37: D412-D416.
35. van Malenstein H, Wauters J, Mesotten D, Langouche L, De Vos R, Wilmer A, van Pelt J,. Molecular analysis of sepsis-induced changes in the liver: microarray study in a porcine model of acute fecal peritonitis with fluid resuscitation. Shock 2010; 34: 427-436.
36. Monbaliu D, Libbrecht L, De Vos R, Vekemans K, Walter H, Liu Q, et al. The extent of vacuolation in non-heart-beating porcine donor liver grafts prior to transplantation predicts their viability. Liver Transpl 2008; 14: 1256-1265.
37. Monbaliu D, van Pelt J, De Vos R, Greenwood J, Parkkinen J, Crabbé T, et al. Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs. Liver Transpl 2007; 13: 239-247. (Pubitemid 46351650)
38. National Center for Biotechnology Information. Gene. Accessed September 2011.
39. Walsh KB, Toledo AH, Rivera-Chavez FA, Lopez-Neblina F, Toledo-Pereyra LH,. Inflammatory mediators of liver ischemia-reperfusion injury. Exp Clin Transplant 2009; 7: 78-93.
40. Barklin A,. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 2009; 53: 425-435.
41. Tacke F, Luedde T, Trautwein C,. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009; 36: 4-12.
42. Luedde T, Trautwein C,. Intracellular survival pathways in the liver. Liver Int 2006; 26: 1163-1174. (Pubitemid 44741203)
43. Viappiani S, Sariahmetoglu M, Schulz R,. The role of matrix metalloproteinase inhibitors in ischemia-reperfusion injury in the liver. Curr Pharm Des 2006; 12: 2923-2934. (Pubitemid 44184626)
44. Boutros T, Nantel A, Emadali A, Tzimas G, Conzen S, Chevet E, Metrakos PP,. The MAP kinase phosphatase-1 MKP-1/DUSP1 is a regulator of human liver response to transplantation. Am J Transplant 2008; 8: 2558-2568.
45. Li B, Yi P, Zhang B, Xu C, Liu Q, Pi Z, et al. Differences in endoplasmic reticulum stress signalling kinetics determine cell survival outcome through activation of MKP-1. Cell Signal 2011; 23: 35-45.
46. Nagata T, Takahashi Y, Sugahara M, Murata A, Nishida Y, Ishikawa K, Asai S,. Profiling of genes associated with transcriptional responses in mouse hippocampus after transient forebrain ischemia using high-density oligonucleotide DNA array. Brain Res Mol Brain Res 2004; 121: 1-11. (Pubitemid 38224164)
47. Tureyen K, Brooks N, Bowen K, Svaren J, Vemuganti R,. Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem 2008; 105: 1313-1324. (Pubitemid 351590795)
48. Zhang Y, Shi G, Zheng J, Lv Y, Gao P, Huang Z, et al. The protective effect of Egr-1 antisense oligodeoxyribonucleotide on myocardial injury induced by ischemia-reperfusion and hypoxia-reoxygenation. Cell Physiol Biochem 2008; 22: 645-652.
49. Zeng S, Dun H, Ippagunta N, Rosario R, Zhang QY, Lefkowitch J, et al. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J Hepatol 2009; 50: 929-936.
50. Huang Z, Li H, Guo F, Jia Q, Zhang Y, Liu X, Shi G,. Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia/reperfusion injury in rats. Cell Physiol Biochem 2009; 24: 17-24.
51. Wang KX, Denhardt DT,. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008; 19: 333-345.
52. Zhang ZX, Shek K, Wang S, Huang X, Lau A, Yin Z, et al. Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury. J Immunol 2010; 185: 967-973.
53. Wang Y, Chen B, Shen D, Xue S,. Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning. Heart Vessels 2009; 24: 116-123.
54. Duval H, Mbatchi SF, Grandadam S, Legendre C, Loyer P, Ribault C, et al. Reperfusion stress induced during intermittent selective clamping accelerates rat liver regeneration through JNK pathway. J Hepatol 2010; 52: 560-569.
55. Xiao JS, Cai FG, Niu Y, Zhang Y, Xu XL, Ye QF,. Preconditioning effects on expression of proto-oncogenes c-fos and c-jun after hepatic ischemia/reperfusion in rats. Hepatobiliary Pancreat Dis Int 2005; 4: 197-202. (Pubitemid 40790165)
56. Wieland E, Oellerich M, Braun F, Schtüz E,. c-fos and c-jun mRNA expression in a pig liver model of ischemia/reperfusion: effect of extended cold storage and the antioxidant idebenone. Clin Biochem 2000; 33: 285-290. (Pubitemid 30670180)
57. Shen SQ, Zhang Y, Xiang JJ, Xiong CL,. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol 2007; 13: 1953-1961. (Pubitemid 46758857)
58. Kerem M, Bedirli A, Pasaoglu H, Ofluoǧlu E, Yilmazer D, Salman B, Yilmaz TU,. Effect of adrenomedullin on hepatic damage in hepatic ischaemia/reperfusion injury in rats. Liver Int 2008; 28: 972-981. (Pubitemid 352044445)
59. Hassan-Khabbar S, Vamy M, Cottart CH, Wendum D, Vibert F, Savouret JF, et al. Protective effect of post-ischemic treatment with trans-resveratrol on cytokine production and neutrophil recruitment by rat liver. Biochimie 2010; 92: 405-410.
60. Jiang W, Kong L, Wu X, Pu L, Wang X,. Allograft inflammatory factor-1 is up-regulated in warm and cold ischemia-reperfusion injury in rat liver and may be inhibited by FK506. J Surg Res 2011; 165: 158-164.
61. Wei Y, Chen P, de Bruyn M, Zhang W, Bremer E, Helfrich W,. Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol 2010; 10: 42.
62. Giakoustidis DE, Giakoustidis AE, Iliadis S, Koliakou K, Antoniadis N, Kontos N, et al. Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-κB and c-Jun expression. J Surg Res 2010; 159: 720-728.
63. Jiang H, Meng F, Li J, Sun X,. Anti-apoptosis effects of oxymatrine protect the liver from warm ischemia reperfusion injury in rats. World J Surg 2005; 29: 1397-1401. (Pubitemid 41712670)
64. Hoffmann F, Sass G, Zillies J, Zahler S, Tiegs G, Hartkorn A, et al. A novel technique for selective NF-κB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion. Gut 2009; 58: 1670-1678.
65. Rhee JY, Alroy J, Freeman RB,. Characterization of the withdrawal phase in a porcine donation after the cardiac death model. Am J Transplant 2011; 11: 1169-1175.
66. Jamieson RW, Zilvetti M, Roy D, Hughes D, Morovat A, Coussios CC, Friend PJ,. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model. Transplantation 2011; 92: 289-295.
67. García-Valdecasas JC, Tabet J, Valero R, Deulofeu R, Taurá P, Rull R, et al. Evaluation of ischemic injury during liver procurement from non-heart-beating donors. Eur Surg Res 1999; 31: 447-456. (Pubitemid 30006837)
68. de Rougemont O, Breitenstein S, Leskosek B, Weber A, Graf R, Clavien PA, Dutkowski P,. One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death. Ann Surg 2009; 250: 674-683.
69. Pirenne J,. Time to think out of the (ice) box. Curr Opin Organ Transplant 2010; 15: 147-149.
70. Pirenne J, Monbaliu D, Aerts R, Desschans B, Liu Q, Cassiman D, et al. Biliary strictures after liver transplantation: risk factors and prevention by donor treatment with epoprostenol. Transplant Proc 2009; 41: 3399-3402.
71. Guarrera JV, Henry SD, Samstein B, Odeh-Ramadan R, Kinkhabwala M, Goldstein MJ, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant 2010; 10: 372-381.
72. Brockmann J, Reddy S, Coussios C, Pigott D, Guirriero D, Hughes D, et al. Normothermic perfusion: a new paradigm for organ preservation. Ann Surg 2009; 250: 1-6.
73. Koetting M, Lüer B, Efferz P, Paul A, Minor T,. Optimal time for hypothermic reconditioning of liver grafts by venous systemic oxygen persufflation in a large animal model. Transplantation 2011; 91: 42-47.